ZK 007Alternative Names: ZK007
Latest Information Update: 15 Oct 2015
At a glance
- Originator Lees Pharmaceutical Holdings
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Dry eyes
Most Recent Events
- 31 Mar 2011 Preclinical trials in Dry eyes in China (unspecified route)